Unknown PHASE2 INTERVENTIONAL NCT00465920

Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis (mCBT)

Sponsor: Goethe University

Conditions Delusional Disorder Psychotic Disorders Schizoaffective Disorder Schizophrenia Schizophreniform Disorder

Interventions modified cognitive behavioural therapy (mCBT)

Updated 7 times since 2017 Last updated: Feb 19, 2009 Started: May 31, 2007 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00465920, this PHASE2 trial focuses on Delusional Disorder and Psychotic Disorders and remains ongoing. Sponsored by Goethe University, it has been updated 7 times since 2007, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status PHASE2
May 2022 — Mar 2023 [monthly]

Unknown Status PHASE2
Jan 2021 — May 2022 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Goethe University
University Hospital Tuebingen
University of Cologne

Data source: University of Cologne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cologne, Germany